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Abstract: Age-related macular degeneration (AMD) is a multifactorial pathology and its progression
is exacerbated by oxidative stress. Oxidation and photo-oxidation reactions modify lipids in
retinal cells, contribute to tissue injury, and lead to the formation of toxic adducts. In particular,
autofluorescent pigments such as N-retinylidene-N-retinylethanolamine (A2E) accumulate as
lipofuscin in retinal pigment epithelial cells, contribute to the production of additional reactive
oxygen species (ROS), and lead to cell degeneration. In an effort to develop efficient antioxidants to
reduce damage caused by lipid oxidation, various natural polyphenols were structurally modified
to increase their lipophilicity (lipophenols). In this study, resveratrol, phloroglucinol, quercetin
and catechin were selected and conjugated to various polyunsaturated fatty acids (PUFAs) using
classical chemical strategies or enzymatic reactions. After screening for cytotoxicity, the capacity of the
synthesized lipophenols to reduce ROS production was evaluated in ARPE-19 cells subjected to H2O2
treatment using a dichlorofluorescein diacetate probe. The positions of the PUFA on the polyphenol
core appear to influence the antioxidant effect. In addition, two lipophenolic quercetin derivatives
were evaluated to highlight their potency in protecting ARPE-19 cells against A2E photo-oxidation
toxicity. Quercetin conjugated to linoleic or α-linolenic acid were promising lipophilic antioxidants,
as they protected ARPE-19 cells from A2E-induced cell death more effectively than the parent
polyphenol, quercetin.
Keywords: AMD; oxidative stress; lipophenol; PUFA
1. Introduction
Nowadays, the interest in natural or synthetic substances to counteract damages produced by
oxidative stress (OS) has risen sharply. Especially for cosmetic, agricultural food or pharmaceutical
purposes, hydrophobic antioxidants are developed, either to protect lipid food matrices, for better
absorption by the skin or to protect cell membranes against lipid peroxidation. In particular, in retina
pathologies such as age-related macular degeneration (AMD, the leading cause of vision loss in the
elderly), OS plays a significant role in the development and aggravation of the pathology. AMD is a
multifactorial, chronic and age-related disease that is influenced by both environmental and genetic
factors. In the dry form of the pathology [1,2], oxidative stress is involved in the toxification
mechanisms leading to N-retinylidene-N-retinylethanolamine (A2E) accumulation and degradation.
A2E is a toxic bis-retinoid derivative, synthesized from vitamin A (trans-retinal), condensation,
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and oxidation. Over the lifespan, A2E and other complex lipids accumulate to form lipofuscin
in the retinal pigment epithelium (RPE), ultimately resulting in photoreceptor degeneration [3,4].
Retinal tissue is particularly predisposed to produce reactive oxygen species (ROS) [2] due to its
high metabolic rate and high oxygen consumption. ROS can also be produced by A2E photo-oxidation
generating singlet oxygen [5]. As A2E displays numerous conjugated double bonds in the structure, it is
prone to oxidation and releases toxic metabolites such as endoperoxides and epoxides [5]. In addition,
as performed on polyunsaturated fatty acids (mainly present in the membrane of photoreceptors),
the lipid peroxidation process is also responsible for A2E cleavage, liberating cytotoxic carbonyl species.
These reactive aldehydes, when formed in toxic concentrations will affect the lipid membranes fluidity,
and damage DNA and cellular proteins [6,7]. It is hypothesized that toxic A2E, its oxidized metabolites
and lipofuscin accumulate when the cellular antioxidant system fails to combat the oxidative-damaged
lipids in the photoreceptor cells [8]. Accumulation and photo-oxidation of A2E are known to be one of
the critical causes of AMD. Therefore, the reduction of lipid oxidation using lipophilic antioxidants is a
promising approach to prevent the progression of AMD [9], similar to the potency of alpha-tocopherol
to reduce A2E degradation [3]. Numerous reports uses ARPE-19 cell lines to investigate pharmacologic
solutions to AMD and for the identification of new compounds to protect RPE cells against A2E
oxidation [10–12].
In the quest to limit the OS involved in AMD and to reduce the progression of this pathology,
many antioxidants have been proposed. Among them, natural plant polyphenol, which are secondary
metabolites that protect plants from microbial pathogens, herbivores as well as solar radiation and,
thus, against OS have been well investigated. An example is resveratrol, a phytoalexin that belongs
to the stilbene family (3,4′,5-trihydroxystilbene) mainly found in Vitis vinifera (Vitaceae) stalks and in
the roots of Fallopia japonica var. japonica (Polygonaceae), showing antioxidant properties [11] and also
anti-neovascularization activity [13] in retinal cells [14]. Also, phloroglucinol, a natural monomer
of phlorotannins abundantly present in Ecklonia cava (edible brown algae, Lessoniaceae) has shown
anti-oxidative and anti-carbonyl stress potency in primary RPE cells [15]. Furthermore, numerous
flavonoids present in high concentrations in fruits, vegetables and other plant-derived food has been
investigated for their antioxidant properties in ARPE-19 and primary human RPE cells [12]. Among the
flavonoids, quercetin, a polyphenol of the flavonol family, has received particular attention by the
scientific community in the field of ocular diseases [16–18], and in protecting RPE cells from A2E
oxidation [19,20].
However, no official consent (FDA or EFSA) has been approved for the use of natural polyphenols
for the treatment of ocular diseases. Despite promising in vitro efficiency for its bioactivity, the main
drawback of polyphenols remains their lack of validation in vivo. Most of the polyphenols have
moderate bioavailability due to their physical and chemical properties, which drive the processes
of absorption, distribution, metabolism and elimination. For the ones that are water soluble due to
their high polarity, it lacks lipophilic properties that could restrict cell penetration and effectiveness in
protecting lipophilic system against oxidation. In contrast, the use of polyphenols such as quercetin that
show poor solubility in water (a major factor in drug absorption) is affected by low bioavailability and
high systemic metabolism during oral administration. Quercetin solubility issues in water or organic
solvents questions the efficacy in in vivo administration and hence the validation of its therapeutic
effectiveness and potential application. Data suggest that increasing the lipophilicity of (natural)
polyphenols may be a useful way to increase their protective effect on lipid matrices, improve their
absorption, and ease their formulation for in vivo administration [21,22].
In search for efficient lipophilic antioxidants to reduce OS and A2E oxidation in RPE cells,
we prepared a library of new polyphenolic compounds, conjugated to PUFAs. Unlike several reports
using lipophilization of polyphenols [23,24], in this study, only one phenolic function of the polyphenol
core is used in the conjugation, to preserve the antioxidant properties of interest while increasing
the affinity and protection of the lipid molecules such as A2E. PUFAs are preferred to saturated
ones, due to their observed benefits in AMD clinical trial [25]. This strategy has already shown
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promising results with acyl-phloroglucinol [26] and resveratrol [27] derivatives when coupled with
docosahexaenoic (C22:6 ω-3, DHA) or linoleic (C18:2 ω-6, LA) acids, for their respective anti-carbonyl
and anti-MMP9 activities in cell culture assays. However, only a few examples in the literature reported
an improved antioxidant effect of polyphenol lipophilization with PUFA [23] compared to the native
polyphenol [28].
Therefore, the purpose of this study was to synthesize novel lipophenol derivatives starting
from known antioxidants (resveratrol, phloroglucinol, quercetin and catechin) and to evaluate the
effect of the polyunsaturated lipid chain on their capacity to maintain ROS scavenging properties.
Both chemical or enzymatic reactions were used to produce mono-acylated lipophenols. The toxicity
of the synthesized lipophenols was determined in ARPE-19 cells at various concentrations using the
MTT test. The ability of lipophenols to block the accumulation of intracellular reactive oxygen species
was examined using a dichlorofluorescein (DCF) probe after H2O2 treatment. Finally, the protective
effects of two quercetin lipophenolic derivatives, that showed no toxicity and the greatest reduction in
ROS production were evaluated at various concentrations in cells stressed with A2E and exposed to
light (photo-oxidation). Two lipophenolic quercetin derivatives were potent antioxidants that reduced
A2E-induced cell death and were more efficient than quercetin itself.
2. Materials and Methods
2.1. Synthesis of PUFA Lipophenols
2.1.1. General Methods
All solvents were anhydrous reagents from commercial sources. Unless otherwise noted,
all chemicals and reagents were obtained commercially and used without purification. Commercial
quercetin or (+)-catechin were dried at 100 ◦C for 48 h under vacuum before use. The reactions
were monitored by using TLC on plates that were pre-coated with silica gel 60 (Merck, Kenilworth,
New Jersey, USA). The reaction components were visualized by using a 254 nm UV lamp, stained
with acidic p-anisaldehyde solution followed by gentle heating. Purifications of the synthesized
compounds were performed by column chromatography on silica gel 40–63 µm. Melting points
(Mp) were determined on a Stuart capillary apparatus and are uncorrected. High resolution mass
spectrometry (HRMS) was recorded using electrospray ionization (ESI) or atmospheric solids analysis
probe (ASAP) techniques on Q-TOF mass spectrometer.
2.1.2. NMR Characterization
NMR spectra were recorded at 300 or 500 MHz (1H) and 75 or 125 MHz (13C) using Bruker
spectrometers. Chemical shifts are reported in parts per million (ppm, δ) relative to residual deuterated
solvent peaks. The NMR spectra were assigned with the help of 2D NMR analyses (COSY, HSQC,
and HMBC). The multiplicities reported are as follows: bs = broad singlet, m = multiplet, s = singlet,
d = doublet, t = triplet, q = quadruplet, qt = quintuplet, or combinations thereof. For the peak
assignments, the following abbreviations were used: Ar = aromatic, TIPS = triisopropylsilyl, CH=CH =
aliphatic alkene, tBu = tert-butyl. Proton numbering was assigned according to IUPAC nomenclature.
2.1.3. UV Spectroscopy
The UV spectra of compounds was performed in methanol LC/MS grade purchased from Fisher
Scientific (France) and were recorded on a UV spectrometer Jasco V-630 apparatus. All spectra were
recorded in the range from 500 nm to 230 nm.
2.1.4. Experimental Session
Experimental procedures of chemical/enzymatic synthesis of all intermediates and final
lipophenols (phloro-LA (3), resv-LA (8), cat-3-LA (9), quer-3-LA (13), quer-3-ALA (14), quer-3-DHA
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(15) and quer-7-ALA (18)) are fully described in the SI. HRMS analysis, 1H-NMR and 13C-NMR
description and spectrum (Figure S2) are described in SI.
2.2. Cell Viability, Cytotoxicity and Antioxidant Activity
2.2.1. Chemicals
All lipophenols were dissolved in dimethylsulfoxide (DMSO) to prepare a stock
solution of 80 mM. Hydrogen peroxide solution (H2O2, 30 wt. % in H2O) and
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) were purchased from
Sigma-Aldrich. N-retinylidene-N-retinylethanolamine (A2E) was synthesized as previously described
by Parish et al. in 1998 [29]. 2′,7′-dichlorofluorescin diacetate (DCFDA) was purchased from
SIGMA-Aldrich (Saint-Quentin, France) and dissolved in DMSO to prepare stock solution at 20 mM.
All stock solutions of lipophenols, A2E and probe were stored at −20 ◦C in the dark.
2.2.2. Cell Culture
ARPE-19 cells were obtained from ATCC (USA) and were grown in Dulbecco’s Modified Eagle’s
Medium (DMEM)/Ham F12 (GIBCO) containing 10% v/v fetal bovine serum (FBS) and 1% v/v
penicillin/streptomycin under atmospheric humidified air (95%)/CO2 (5%) at 37 ◦C. For experimental
cell seeding and sub-culturing, the cells were dissociated with 0.25% trypsin-EDTA, resuspended in
the culture medium and then plated at 1–3 × 105 cells/mL. ARPE-19 cells were cultured and used up
to 15 passages maximum.
2.2.3. Cell Viability
Cell viability was determined by MTT colorimetric assay. The cells were incubated for 2 h with
MTT reagent (0.5 mg/mL). During this incubation time, dehydrogenases of the living cells reduce the
MTT to insoluble purple formazan. The absorbance at 570 nm and 655 nm of individual wells of the
cell was measured using a microplate reader (BioRad 550, USA). The absorbances of the compounds
tested does not interfere with the absorbance at 570 and 655 nm. The percentage of the viable cells was
calculated as [(OD570 sample − OD655 sample)/(OD570 control − OD655 control)] × 100%.
2.2.4. Cytotoxicity of Lipophenols
ARPE-19 cells were plated into 96-well plates (4 × 104 cells/well) and cultured for 24 h to
reach confluence before lipophenol treatment. The cell cultures were treated with serum free medium
containing the lipophenols at different concentrations (0–160 µM) for 24 h. Control cells were incubated
with DMSO (0.2%). The viability of the cells was determined using MTT colorimetric assay as described
above and expressed in percentage of viable cells normalized with control conditions in the absence of
lipophenols. When a dose-dependent toxicity was observed, CC50 was calculated.
2.2.5. Protection of Lipophenols against ROS Production
ROS activity was measured in ARPE-19 cells with dichlorofluorescein diacetate (DCFDA) reagent.
DCFDA is deacetylated by cellular esterases to dichlorofluorescein (DCFH), which can then be oxidized
by ROS into the fluorophore 2′,7′–dichlorofluorescein (DCF). ARPE-19 cells were plated into black,
optically clear bottom 96-well plates (4 × 104 cells/well) and cultured for 24 h to reach confluence
before the drug treatment. The cell cultures were incubated with 2 µM of DCFDA for 45 min in
DMEM/F12 medium without phenol red + 1% FBS. The cells were rinsed and incubated with the
medium containing lipophenols at different concentrations (0–80 µM) for 1 h. Then, H2O2 was added
to a final concentration of 600 µM for 4 h, followed by the measurement of DCF production by
fluorescence spectroscopy with excitation wavelength at 485 nm and emission wavelength at 535 nm.
The fluorescence of the compounds tested does not interfere with DCFDA signal. Control cells were
incubated with DMSO (0.2%) ± DCFDA ± H2O2. The percentage of ROS produced was calculated as
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[(fluorescence of sample)/(fluorescence of control)] × 100%. The results are expressed in percentage
of ROS produced normalized with control conditions in the absence of lipophenol and presence of
stressor. When a dose-dependent inhibition was observed, IC50 was calculated.
2.2.6. Protection of Lipophenols against Photo-Oxidized A2E Toxicity
ARPE-19 cells were plated into 96-well plates (4 × 104 cells/well) and cultured for 24 h to reach
confluence before lipophenol treatment. The cell cultures were treated with serum free DMEM/F12
medium without phenol red containing lipophenols at different concentrations (0–80 µM) for 1 h.
Then A2E was added to a final concentration of 20 µM for 6 h before rinsing with medium. Control
cells were incubated with DMSO (0.2%) with or without A2E. The cells were exposed to intense blue
light (4600 LUX) for 30 min to induce phototoxicity of A2E and incubated at 37 ◦C. The cell viability
was determined 16–20 h later using a MTT colorimetric assay. Results are expressed in percentage of
viable cells normalized with control conditions in the absence of lipophenols and stressor. When a
dose-dependent efficiency was observed, IC50 was calculated.
2.2.7. Statistical Analysis
The data are presented as means ± SD determined from at least three independent experiments.
In each experiment, all conditions were done at least in quadruplicate. Statistical analysis was
performed by Student’s t-test for Gaussian distributions or non-parametric Mann-Whitney’s test for
non-normal distributions (the normality of distributions was highlighted with a Shapiro-Wilk test)
and differences with p-values < 0.05 were considered as statistically significant. CC50 and IC50 were
calculated using GraphPad Prism version 5.03 and linear regression.
3. Results
3.1. Chemical and Enzymatic Synthesis of PUFA Lipophenols
Seven lipophenols were synthesized using natural phenolic compounds, phloroglucinol,
resveratrol, quercetin and catechin. First, linoleic acid (C18:2, ω-6; LA) was selected to compare
different family of phenolic compound. To better appreciate the impact of the lipid chain, additional
fatty acid such as linolenic (C18:3, ω-3; ALA) and docosahexaenoic (C22:6, ω-3; DHA) acids were
linked to the quercetin series and compared to the LA analogue. Finally, the impact of the PUFA
position on the quercetin core was evaluated by the synthesis of both quercetin-7-ALA (quer-7-ALA)
and quercetin-3-ALA (quer-3-ALA).
3.1.1. Phloroglucinol and Resveratrol Conjugates
Synthesis of Phloroglucinol-LA
Phloroglucinol-LA derivative was synthesized following the strategy developed by Crauste et
al. [26] (Figure 1) using silylated protecting group for a single PUFA coupling. Briefly, hydroxyl groups
of the phloroglucinol are protected by triisopropylsilyl (TIPS) groups using triflate reagent (TIPS-OTf)
and diisopropylethylamine (DIPEA) as a base to obtain a tri-protected derivative. One TIPS function
was deprotected by carefully following the reaction on TLC using triethylamine trihydrofluoride
(Et3N.3HF) and afforded the mono deprotected compound 1. The coupling reactions between the
protected phloroglucinol and the linoleic acid (LA) was initiated using dicyclohexylcarbodiimide
and dimethylaminopyridine (DCC/DMAP) as coupling reagents to access to protected lipophenol 2.
Final deprotection of TIPS protecting groups by Et3N.3HF in dry tetrahydrofuran (THF) yielded final
lipophenol compound without ester degradation (3, phloro-LA).
Antioxidants 2018, 7, 197 6 of 18
Antioxidants 2018, 7, x FOR PEER REVIEW  6 of 19 
 
Figure 1. Synthetic pathway to access phloroglucinol-LA. 
Synthesis of Resveratrol-4′-LA 
The work of Vlachogianni et al. [30] show better radical scavenging activity of 4′-acetylated 
resveratrol compared to 3-acetylated analogues; we decided to link the fatty acid at the 4′ position of 
resveratrol. Another argument for choosing this coupling position was to keep the resorcinol moiety 
accessible, which appears to be involved in trapping steps of toxic aldehyde in phloroglucinol or 
flavonoid structures [15,31]. The synthesis of resveratrol-4′-LA was performed as previously 
described [27] (Figure 2) using an enzymatic chemical strategy allowing to isolate only the 4′-acylated 
analogue. Using a freshly (and not recycled one) supported lipase Candida antartica (CALB, 
Novozyme 435), a first acetyl group was regio-selectively introduced at the 4’ position in good yield 
(85%) without any acetyl derivatives in 3 or 5 positions. The resv-LA (8) was then obtained in four 
steps; hydroxyl silyl protection, 4′-acetate enzymatic deprotection, fatty acid coupling and a final silyl 
deprotection, with 52% overall yield in 4 steps. 
 
Figure 2. Synthetic pathway to access resveratrol-4′-LA. 
3.1.2. Catechin and Quercetin Conjugates 
Synthesis of Catechin-3-LA 
In catechin structure, the position of the fatty acid was selected according to the study of Hong 
et al. [32]. Radical scavenging properties seem to be less affected by acylation at the 3 or 7 position 
compared to acylation of the catechol moiety. Position 3 was thus selected to design catechin 
lipophenol. In order to avoid multiple step synthesis, including protection/deprotection strategy 
[33,34] and access quickly to the desired catechin-3-LA, we investigate the preferential reactivity of 
aliphatic hydroxyl under acidic conditions, compared to the phenolic hydroxyls. Under 
undissociated form, aliphatic hydroxyl should be more nucleophilic than the phenolic ones [32]. 
Coupling step was thus realized according to Uesato et al. [35] using TFA and linoleoyl chloride 
freshly prepared (Figure 3). Unfortunately, mono-acylated cat-3-LA (9) was isolated in weak yield 
using this process, but in sufficient amount to evaluate its antioxidant potency. Confirmation of the 
structure and verification of introduction of the LA moiety in position 3 has been validated according 
to Park et al. [36] by a 1H NMR shift of proton H3 (from 3.8 ppm for commercial (+)-catechin to 5.2 
ppm for 3-R-derivatives). 
HO OH
OH
1) TIPS-OTf
THF, rt, 2 h
2) Et3N.3HF
THF, rt, 4 h
59%
TIPSO OH
OTIPS
1 3
phloro-LA
LA, DCC, DMAP
CH2Cl2, rt, 2 h
62%
Et3N.3HF, THF
rt, 9 h
92%
TIPSO O
OTIPS
2
O
HO O
OH
O
OH
HO
OH
OH
HO
OAc
85%
OTIPS
TIPSO
OAc
OTIPS
TIPSO
OH
4 5
6
90%
95%
TIPS-OTf, DIPEA
CH2Cl2/THF, rt, 7 h
1
2
3
4
5
6 7
8
1'
2'
3'
4'
5'
6'
A
B
 74%
Et3N.3HF 
THF, rt, 8 h
 83%8
resv-LA
4'
2-methylbutan-2-ol
Vinyl acetate, Novozyme 435
40 °C, 4 days
MeONa,
MeOH/CH2Cl2
rt, 6.5 h
LA, DCC, DMAP
CH2Cl2, rt, 3 h
OTIPS
TIPSO
O7
O
OH
HO
O
O
Figure 1. Synthetic pathway to access phloroglucinol-LA.
Synthesis of Resveratrol-4′-LA
The work of Vlachogianni et al. [30] show better radical scavenging activity of 4′-acetylated
resveratrol compared to 3-acetylated analogues; we decided to link the fatty acid at the 4′ position
of resveratrol. Another argument for choosing this coupling position was to keep the resorcinol
moiety accessible, which appears to be involved in trapping steps of toxic aldehyde in phloroglucinol
or flavonoid structures [15,31]. The synthesis of resveratrol-4′-LA was performed as previously
described [27] (Figure 2) using an enzymatic chemical strategy allowing to isolate only the 4′-acylated
analogue. Using a freshly (and not recycled one) supported lipase Candida antartica (CALB, Novozyme
435), a first acetyl group was regio-selectively introduced at the 4’ position in good yield (85%) without
any acetyl derivatives in 3 or 5 positions. The resv-LA (8) was then obtained in four steps; hydroxyl
silyl protection, 4′-acetate enzymatic deprotection, fatty acid coupling and a final silyl deprotection,
with 52% overall yield in 4 steps.
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3.1.2. Catechin and Quercetin Conjugates
Synthesis of Catechin-3-LA
In catechin structure, the position of the fatty acid was selected according to the study of Hong
et al. [32]. Radical scavenging properties seem to be less affected by acylation at the 3 or 7 position
compared to acylation of the catechol moiety. Position 3 was thus selected to design catechin lipophenol.
In order to avoid multiple step synthesis, including protection/deprotection strategy [33,34] and
access quickly to the desired catechin-3-LA, we investigate the preferential reactivity of aliphatic
hydroxyl under acidic conditions, compared to the phenolic hydroxyls. Under undissociated form,
aliphatic hydroxyl should be more nucleophilic than the phenolic ones [32]. Coupling step was thus
realized according to Uesato et al. [35] using TFA and linoleoyl chloride freshly prepared (Figure 3).
Unfortunately, mono-acylated cat-3-LA (9) was isolated in weak yield using this process, but in
sufficient amount to evaluate its antioxidant potency. Confirmation of the structure and verification of
introduction of the LA moiety in position 3 has been validated according to Park et al. [36] by a 1H
NMR shift of proton H3 (from 3.8 ppm for commercial (+)-catechin to 5.2 ppm for 3-R-derivatives).
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Figure 3. Synthetic pathway to access catechin-3-LA.
Synthesis of Quercetin-3-LA, 3-ALA, 3-DHA and 7-ALA
Quercetin is rapidly metabolized after administration, and the 3-conjugates are commonly found
as main metabolites (3-glucuronide) [37]. Selecting the position 3 to link the PUFA may affect the
metabolism of quercetin leading to its elimination. A chemical/enzymatic strategy that avoids
multistep synthesis was investigated to access the quercetin-3-LA derivative. To evaluate the impact of
the PUFA chains during in vitro assays, DHA (the main PUFAs present in photoreceptor membrane)
and ALA analogues were also synthesized.
To access 3-O-acyl-quercetin derivatives, two esterification methods were performed (Figure 4).
A first penta-O-acylation was realized either using fatty acyl chloride (for quer-3-LA strategy,
compound 10, 75%) or a less fatty acid consuming method using Steglich esterification (for ALA
and DHA coupling compound 11 and 12). Then, the regioselective deprotection of PUFA at the 5, 7, 3’
and 4’ position was performed using supported lipase from Mucor miehei (immobilised, Lipozyme®
IM). This process has been previously described for the synthesis of saturated 3-O-acyl-quercetin [38],
but has never been applied for the synthesis of unsaturated analogues. This enzymatic process is
completed over 6 to 8 days depending on the lipid chain and afforded desired compounds quer-3-LA
(13), quer-3-ALA (14) and quer-3-DHA (15) with moderate to good yields.
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Figure 4. Synthetic pathway to access quercetin-3-LA, 3-ALA and 3-DHA.
To end, we investigated the effect of acylation of the PUFA (using ALA) at the 7 position compared
to the 3 position, since both positions should be less inv sted in radical scavenging proper es.
The synthesis of quer-7-ALA was perf rmed in three steps from the commercial quercetin (Figure 5).
Protection of po itions 3, 3′ and 4′ with tert-butyl dimethylsilyl ethers (16) allowed the introduction of
ALA chain via a S eglich esterification (17) on pos ion 7, wi hout touching th 5 position involved in
hydrogen bond. Final deprotection of the silyl groups afforded quer-7-ALA (18) with 61% y eld.
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Figure 5. Synthetic pathway to access quercetin-7-ALA.
To carefully validate the position of ALA derivative on both 7- and 3-isomers (18 and 14), 1H and
13C NMR shift between both compounds and natural quercetin (Table 1) were first analyzed using
quercetin as reference. Higher chemical shift variations of H6, H8 and C7 signals were obtained with
7-ALA isomer compared to the 3-ALA derivative, whereas shielding was observed for C3 signal only in
quer-3-ALA analysis. Since position of the fatty acid could not be deeply confirmed by Heteronuclear
Multiple Bound Connectivity (HMBC) NMR analysis, characteristic UV spectrum of flavonoid was
used to confirm the position of acylation [39]. The UV spectrum of quer-7-ALA exhibits two absorption
maxima at 255 and 376 nm (band II and I Figure 6a). A bathochromic shift of the first maximum
(band II—characteristic of the hydroxyl benzoic group) upon the addition of sodium acetate (AcONa)
was not observed in contrast with the case of quer-3-ALA (Figure 6b, from 256 nm to 272 nm). Since the
weak base AcONa is able to deprotonate the more acidic 7-OH [40], this experiment confirmed the
presence of a substituent at the 7-position on the quer-7-ALA and its absence on the quer-3-ALA.
The absence of catechol substitution was then confirmed in both structures using first AlCl3 treatment
(bathochromic shift of band I characteristic of the cinnamic system is observed due to aluminum
chelation with the catechol diol) and then upon addition of HCl (cleavage of the unstable complex
leading to a hypsochromic shift of the same band). To end, the 5-position of both structures was not
acylated according to AlCl3 complex formation (band II, bathochromic effect), which is stable after
addition of HCl.
Table 1. Chemical shifts (δ) of the aromatic protons and carbons of natural quercetin [41] (quer),
quer-3-ALA (14) and quer-7-ALA (18) in methanol-d4, expressed in ppm.
Compound δ (H-6) δ (H-8) δ (H-2′) δ (H-5′) δ (H-6′)
quer 6.18 6.39 7.73 6.89 7.63
quer-3-ALA (14) 6.23 6.42 7.33 6.88 7.27
quer-7-ALA (18) 6.46 6.81 7.77 6.88 7.65
Compound δ (2-C) δ (3-C) δ (4-C) δ (4a-C) δ (6-C) δ (7-C) δ (8-C)
quer 148.03 137.20 177.33 104.50 99.28 165.73 94.45
quer-3-ALA (14) 158.42 131.45 177.21 105.29 100.14 166.25 95.04
quer-7-ALA (18) 149.31 138.02 177.62 108.49 104.82 157.19 101.86
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3.2. Toxicity of Lipophenols in ARPE-19 Cells
First, the toxicity of synthesized lipophenols was evaluated in a RPE cell line (ARPE-19). ARPE-19
cell line is widely used in AMD studies for testing potential new drug candidates [10,26,42]. Even if they
do not express the exact cellular characteristics of primary RPE cells, they display similar physiological
properties than RPE cells in vivo [43]. All the compounds were tested at various concentrations in the
range of 0–160 µM (Table 2, ARPE-19 CC50). All phloroglucinol and resveratrol derivatives showed
no toxicity up to 160 µM in this cell line. Natural catechin showed no apparent toxicity, whereas its
lipid derivative (9, entry 6) displayed a slight mortalit at high concentrations (CC50 = 148.63 µM).
Natural quercetin showed a moderat toxicity (entry 7) that was increased or decreased by the presence
of the lipid component, dep nding on the nature of the PUFA and the position in the polyphenol moiety.
For quer-3-LA ( ntry 8), no toxicity was obs ved up to 160 µM, whereas a slight toxicity was observed
for t e quer-3-DHA (entr 9) and even a high toxicity (IC50 = 69.44 µM) was displayed by quer-3-ALA
(entry 10). Surprisingly, the toxicity disappeared with the same lipid (ALA), when introduced in
position 7 instead of 3 (entry 11).
Table 2. Cytotoxicity and antioxidant potential of lipophenols against induced ROS production.
Entry Compound ARPE-19 CC50 1 ROS production IC50 2
1 Phloroglucinol >160 10.25 ± 3.44
2 Phloro-LA (3) >160 >80
3 Resveratrol >160 7.40 ± 0.51
4 esv-4′-LA (8) >160 >>80
5 (+)-catechin >160 5.93 ± 0.06
6 at-3-LA (9) 148.63 ± 6.61 10.61 ± 4.41 uuu
7 Quercetin 111.45 ± 4.92 6.82 ± 0.73
8 Quer-3-LA (13) >160 52.25 ± 10.84 ***
9 Quer-3-DHA (15) 134.10 ± 8.09 *; ◦◦◦ 59.42 ± 18.80 ***
10 Quer-3-ALA (14) 69.44 ± 3.46 *** 61.72 ± 7.43 ***
11 uer-7-ALA (18) >160 9.44 ± 2.37 **; ###
Results are expressed in concentrations (µM) ± SD and are mean of at least n = 3 independent experiments.
1 Concentration of lipophenol killing 50% of ARPE-19 cells. 2 Concentratio f lipophenol needed to inhibit 50%
of the ROS induced by H2O2. Student’s t-test was applied for CC50 and Mann-Whitney’s test was applied for
ROS production IC50. * p < 0.05, ** p < 0.01, *** p < 0.001, versus natural quercetin (entry 7). ◦ p < 0.05, ◦◦ p < 0.01,◦◦◦ p < 0.001, versus quer-3-ALA (entry 10). u p < 0.05, uu p < 0.01, uuu p < 0.001, versus (+)-catechin (entry 5).
# p < 0.05, ## p < 0.01, ### p < 0.001, versus quer-3-ALA (entry 10).
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3.3. Inhibition of ROS Production by Lipophenol Pre-Treatment in ARPE-19 Cells
The antioxidant potential of the lipophenols was evaluated with a ROS inhibition test. Briefly,
lipophenols were incubated 1 h in cells before addition of H2O2 stressor at a high concentration
(600 µM). The level of produced ROS was measured with a fluorescent probe DCFDA [44]. The results
are presented in Table 2 (ROS production IC50) and expressed as the concentration of lipophenol
required to reduce 50% of the ROS produced in H2O2 stress conditions. For the phloroglucinol
lipophenol, (entry 2) the antioxidant potency was lower than its natural analogue. As with the
resveratrol-4′-LA (entry 3), antioxidant properties were not conserved since IC50 was higher than 80 µM.
For the catechin analogue (entry 6), ROS inhibition seems to be in the same range than the natural
catechin (IC50 = 10.61 µM versus 5.93 µM). When considering the quercetin analogues, the antioxidant
potency of the 3-LA, 3-DHA and 3-ALA decreased by the presence of the lipid with equivalent potency,
regardless of the lipid moiety introduced (IC50 from 52 to 62 µM). Finally, quer-7-ALA (entry 11)
displayed the best antioxidant activity of the quercetin analogues with IC50 = 9.44 µM, and was more
potent than its homologue 3-ALA.
3.4. Lipophenols Protected RPE Cells from A2E Photo-Oxidation Toxicity
It is well known that when human RPE is irradiated at an excitation maximum in the blue
region of the spectrum, A2E generates various reactive forms of oxygen in addition to endoperoxides,
epoxides and furanoid moieties [45]. Since this phenomenon plays a crucial role in the progression of
AMD, two candidates were selected to evaluate their ability to protect ARPE-19 cells from toxicity of
photo-oxidized A2E, based on their absence of toxicity and their efficiency to reduce ROS production.
Although catechin-3-LA displayed a good antioxidant activity, it has not been selected due to its
cytotoxicity on ARPE-19 starting from 80 µM and its poor accessibility. Among quercetin lipophenols
that did not show any toxicity up to 160 µM, quer-3-LA and quer-7-ALA were further evaluated
and compared to quercetin, as they showed the most interesting antioxidant properties in the ROS
inhibition assay. In the test, the drugs were pre-incubated for 1 h prior addition of A2E. After 6 h
of incubation, the medium was rinsed and the cells were exposed to intensive blue light for 30 min
before overnight incubation. Results are shown in Figure 7. The two quercetin derivatives (compounds
13 and 18) showed similar protective effect on ARPE-19 cells when exposed to photo-oxidized A2E.
They were able to decrease the toxic effect of A2E from 50% at 8 µM only and were able to protect up
to 90% of cells at higher concentrations. The protection of both flavonoid lipophenols was higher than
the one produced by quercetin treatment.
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Figure 7. Protecting effect of quercetin (a), quer-3-LA (b) and quer-7-ALA (c) against photo-oxidized 
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Figure 7. Protecting effect of quercetin (a), quer-3-L (b) and quer-7-ALA (c) against photo-oxidized
A2E, represented as cell viability (%) in function of the used drug concentration (µM) i.e., cells exposed
to A2E and non-treated. Results are expressed in mean ± SD and are from at least n = 3 independent
experiments. Results are normalized with 100% viability for non-treated and non-exposed to A2E
toxicity control cells. 1 Concentration of lipophenol needed to inhibit 50% of the toxicity induced
by photo-oxidized A2E. Mann-Whitney’s test, # p < 0.05, ## p < 0.01, ### p < 0.001, versus natural
quercetin. Mann-Whitney’s test, * p < 0.05, ** p < 0.01, *** p < 0.001, versus non-treated cells exposed to
photo-oxidized A2E.
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4. Discussion
Oxidative stress is one of the major toxic mechanisms responsible for age-related RPE damages.
Many studies have demonstrated that accumulation of lipid deposit called lipofuscin, generates
reactive oxygen species through phototoxicity in RPE cells [3]. Oxidative stress caused by
photo-oxidation of bis-retinoid A2E (a component of lipofuscin) is known to be a critical cause not only
in AMD progression, but also in genetic macular degeneration such as Stargardt disease. In this context,
the reduction of lipid peroxidation using lipophilic antioxidants derived from natural antioxidant
molecules was a logical choice to reduce deleterious oxidative stress. Four natural phenolic derivatives
were selected in this study for their potent antioxidant properties or for their previous evaluation in
RPE cell assays: phloroglucinol [15], resveratrol [14], catechin, and quercetin [46,47]. Among them,
natural quercetin has been largely evaluated in the field of retina dystrophies for its direct or indirect
antioxidant properties: Cao et al. [18] demonstrated the ability of quercetin to protect human RPE
cells from oxidative stress in vitro via suppression of pro-inflammatory cytokines and inhibition of
apoptosis pathway. Hytti et al. [48] performed in vitro evaluation of quercetin after exposure of cells
to the lipid peroxidation end product 4-hydroxynonenal (HNE) and found that quercetin was able
to increase cell viability under these conditions but was also able to reduce inflammatory mediators.
Recently Wang et al. [20] demonstrated the ability of quercetin and cyanidine-3-glucoside to protect
RPE cells against light damage by inhibiting the photo-oxidation and photo-degradation of bis-retinoid.
To increase their protection of lipid molecules, and to protect them from polyphenol loss through
metabolic and excretion process, the four selected phenolic derivatives were esterified at one phenolic
position with different PUFAs. In this investigation, a single PUFA was incorporated in the phenolic
backbone to minimize the interference of the antioxidant properties. The potency to limit ROS
production and protect cells against A2E photo-oxidation was evaluated in ARPE-19 cells.
4.1. Chemical and Enzymatic Synthesis of Lipophenols
The preferred position of the lipid substitution was position 4’ for the resveratrol backbone, since
some studies showed the best antioxidant activities when the phenols at the 3 and 5 positions were not
functionalized [30]. When considering (+)-catechin backbone, position 3 was linked to the lipid moiety
since phenolic functions in position 3 was found to be the less important for scavenging activity of
ROS [32]. Furthermore, the same choice was made for quercetin derivatives. Position 3 was esterified
by different PUFAs, either ω-3 or ω-6 (LA, ALA and DHA), to compare their contribution to the
antioxidant activity. Position 7 was also substituted by ALA chain to investigate the impact of the fatty
acid position on the quercetin series.
To incorporate only one lipid part, chemical strategies were chosen either using
protection/deprotection steps of the phenolic functions or using stereo-selective enzymatic reactions.
Using a previous chemical strategy [26] and by TIPS protection of the phenolic functions, the synthesis
of phloroglucinol derivative was performed in four steps to access desired compound phloro-LA (3)
with 34% overall yield. When considering resveratrol series, the synthesis performed as described
by Shamseddin et al. [27] allowed to isolate the desired resv-4′-LA (8). The global yield of the
strategy was improved due to the amelioration of the 4′-enzymatic acetylation using a non-recycled
supported lipase Candida antartica (CALB, Novozyme 435). For the catechin series, a single step
synthesis was performed, but had weak yield. Finally, two different pathways were developed to
access 3- or 7-quercetin derivatives substituted with different fatty acids. The synthetic pathway used
to access 3-PUFA quercetins, quer-3-LA (13), quer-3-ALA (14) and quer-3-DHA (15), starts with a full
penta-acylation of the phenolic functions of the quercetin followed by a stereoselective enzymatic
cleavage using the supported lipozyme from Mucor miehei. This process was previously described
for the synthesis of saturated 3-O-acyl-quercetins [38], which showed the selectivity of the enzyme
(avoiding the 3-position) using saturated fatty acids. We validated for the first time the methodology
using PUFA (LA, ALA and DHA). Only recently, Carullo et al. [49] described another enzymatic
pathway to access quercetin-3-oleate derivative in a single step from quercetin and oleic acid (C18: 1,
Antioxidants 2018, 7, 197 12 of 18
ω-9) by using pancreatic porcine lipase. This methodology is a promising work and may be adapted
in future to our derivatives using polyunsaturated fatty acids such as DHA.
4.2. How Does PUFA Introduction Influence Toxicity of Phenols in ARPE-19 Cells?
Cytotoxicity evaluation of the derivatives in this study showed that the LA introduced in
phloroglucinol and resveratrol series had no enhanced toxicity in ARPE-19 cells compared to their
natural homologue. Concerning the catechin derivative, a small toxic effect due to the LA introduction
at position 3 was noted. For quercetin derivatives, it was found that the nature of the lipid moiety was
significant. When substituted with LA (position 3), an important protective effect of the lipophenol
was observed in the cells (150% survival at 80 µM, Figure 8), whereas natural quercetin displayed
a CC50 of 111.45 µM and showed no protective effect. When substituted with DHA at the same
position, the protective effect of lipophenol was reduced but still present at lower concentration before
showing toxicity signs resulting in shifted CC50 (134.10 µM) compared to natural quercetin (Figure 8).
These protective effects of lipophilic quercetins could be explained by an enhanced cell penetration
of the compounds due to the association of a lipid moiety to the flavonoid [50] and/or the action of
the PUFA itself. The mechanism by which lipophenol may increase cell viability could be through
enhancement of the cell integrity and/or the induction of cell proliferation. Indeed, beneficial effects
of DHA as an antioxidant and protective agent have been already described [51,52] in RPE cells,
in patients, and rats. Surprisingly, when substituted with ALA at position 3, an enhanced toxicity
was observed with a CC50 = 69.44 µM and an acute toxicity up to 80 µM. This result shows that the
nature of the lipid is important to observe a protective effect of 3-PUFA quercetin derivatives on RPE cells.
The different toxicity profiles obtained using ALA (ω-3) derivative compared to LA (ω-6) and DHA (ω-3)
may be highlighted by the different roles and functions of each PUFA and PUFA metabolites, which are
represented as cell mediators and signaling molecules in the cell [53,54]. One can hypothesize that spatial
conformation of the lipophenol may also play a role resulting in different stability in the cells. Finally,
toxicity evaluation of quer-3-ALA versus quer-7-ALA brings to light the importance of the substituent
position on the backbone. Indeed, the toxic effect observed with quer-3-ALA (CC50 = 69.44 µM) disappears
for the 7-ALA isomer. Furthermore, quer-7-ALA displays a protective effect on cells with no evidence of
toxicity and increased viability (128%, Figure 8) up to 160 µM.Antioxidants 2018, 7, x FOR PEER REVIEW  13 of 19 
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4.3. Antioxidant Properties of Lipophenols: ROS Scavenging and Protection against Oxidized A2E
For most of the series (phloroglucinol, resveratrol and quercetin), an important loss of ROS
scavenging properties was observed when one lipid is associated to the phenolic backbone. For the
phloroglucinol derivative, phloro-LA is nine times less potent than its natural homologue. Regarding
the resveratrol series, this loss is even more important as only 40% of ROS is scavenged by resv-LA at
80 µM (Figure S1). The same result was observed by Oh et al. [55] in non-cellular DPPH and ABTS
assays, where substitution of hydroxyl group(s) appeared to negatively affect the antioxidant activity of
the resveratrol derivatives. Natural quercetin displayed a high antioxidant activity with an IC50 in the
same range compared to phloroglucinol, resveratrol and (+)-catechin. When position 3 was substituted
by one LA moiety (quer-3-LA), ROS scavenging properties were highly decreased but still more
potent than its homologues phloro-LA and resv-LA. Mainini et al. [24] evaluated fatty acid-quercetin
derivatives using either stearic, oleic, linoleic or linolenic acids to form penta-(3,5,7,3′,4′), tetra-(3,7,3′,4′)
or tri-(7,3′,4′) esters and also demonstrated, in non-cellular assay, a systematic decrease of antioxidant
properties of the lipophenol derivatives associated with the number of phenolic function esterified.
This subsiding activity has been frequently observed in DPPH or ABTS non-cellular antioxidant
assays performed on lipophilized polyphenols [24,56–58]. However, different conclusions have been
described from experiments carried out in a bulk oil system, where, for example, resveratrol ester
is able to outperform the antioxidant capacity of the original resveratrol [59]. By performing ROS
inhibition assay in a cellular media, one could anticipate that the increase in cell penetration (due to
increased lipophilicity) confers to the lipophilic derivatives a more potent effect than their native
polyphenol. However, this was not observed. This decreased ROS scavenging potency could be
explained by the loss of a phenol function due to introduction of the fatty acid but could not be the
only explanation since lipophilized phlroridzin, rutin or isoquercitrin have shown reduced antioxidant
capacity even when the lipid part was localized on the sugar hydroxyl, which does not participate in
the ROS scavenging mechanism [57,58].
Interestingly for the catechin series, lipophenol cat-3-LA displays the same range of antioxidant
activity as the natural compound, suggesting that aliphatic hydroxyl in position 3 was not essential
for ROS scavenging activity. The same conclusion was highlighted by Jin et al. in 2005 [60] by
evaluating radical scavenging activity of 3-lauroyl; 3′,4′-dilauroyl- and 3,3′,4′-trilauroyl-(+)-catechins
in a DPPH test. They showed a conserved antioxidant potential of the 3-lauroyl derivative compared
to natural catechin. Perera et al. [61] recently evaluated the antioxidant properties of epigallocatechin
gallate (EGCG) tetra-esters substituted with different fatty acid chains and observed the highest DPPH
scavenging activity for EGCG-DHA derivative. The group also evaluated the protective effect of their
derivatives in various food model and biological systems and concluded on the major role of the
lipophilicity and chain length of fatty acids in the antioxidant capacity of the derivatives.
Not taking into account their toxicity profile, the most interesting antioxidant lipophenol
conjugated to LA was cat-3-LA > quer-3-LA > phloro-LA >> resv-4′-LA. In spite of this observation,
cat-3-LA displayed a mild toxicity at concentrations higher than 80 µM compared to quer-3-LA,
which showed a protective effect on cells even at high concentrations (up to 160 µM) on toxicity
assay (Figure 8). The choice of the fatty acid was also evaluated using quercetin backbone leading
to 3-LA, 3-DHA and 3-ALA derivatives. By comparing their antioxidant profile, it can be concluded
that their efficiency is in the same range (IC50 approximately 60 µM), regardless of the type of
lipid part introduced. The presence of a PUFA moiety in position 3 systematically reduced ROS
scavenging activity of quercetin independently of the nature of the PUFA (LA, ALA or DHA). Finally,
the comparison of quer-3-ALA with quer-7-ALA led to the conclusion that position 3 is more important
than the 7 position to display a high antioxidant effect of the flavonoid. Quer-7-ALA was 6 times more
potent to scavenge ROS than its analogue 3-ALA. This result is in line with the literature reporting that
positions 5 and 7 are less important for ROS scavenging [23,24].
The two most promising compounds in terms of non-toxicity and ROS scavenging properties
were evaluated for their capacity to protect cells from photo-oxidized A2E and compared to native
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quercetin efficiency. Quercetin was able to rise a maximum of 78% of cell viability when used at 40 µM.
This result is in line of what was observed by Sparrow’s group, who used quercetin in the same cell
model [20]. In our investigation, quer-3-LA and quer-7-ALA were able to efficiently increase cell
viability in the presence of toxic A2E and displayed similar protective effect with IC50 in the same
range (8.24 and 8.45 µM, respectively). A maximum of 88–89% of cell viability was observed between
20 and 40 µM concentrations. Same level of protection was observed previously using resveratrol or
piceatannol at 60 µM in ARPE-19 cells treated by photo-oxidized A2E [11]. However, compared to our
procedure (1 h of lipophenol pretreatment), cells were treated twice with resveratrol or piceatannol
for a duration of 3 days before A2E stress. As recently observed by Kim et al. [19] with 3-quercetin
glycoside, the esterification of the phenol function in position 3 was compatible with the protection
against A2E induced toxicity. Kim’s group showed efficiency of 3-quercetin glycoside to protect
RPE cells (~90% of cell viability at 100 µM) and Balb-c male mice photoreceptors against blue light
damages. In our study, the efficiency of quercetin lipophenols was also comparable with the report
using Norbixin [62]. This natural lipid diapocarotenoid shown high protection (~90–100% at 20 µM)
against A2E illuminated in porcine primary RPE cells, and was also able to reduce A2E in Abca4 −/−
Rdh8 −/−mice treated orally for three months. The protection we highlighted with quer-3-LA and
quer-7-ALA appears to be slightly more significant than those of curcumin derivatives that showed a
maximum rise of 60–70% of cell viability (3 days incubation at 20 µM) in ARPE-19 cells subjected to
photo-oxidized A2E [63].
Interestingly, in our study, quer-3-LA and quer-7-ALA both are three times more potent than
the natural quercetin (IC50 = 23.90 µM). This result contrasts with the ROS inhibition test; indeed,
in A2E photo-oxidized assay, natural quercetin displayed a lower antioxidant activity than the two
lipophenolic derivatives. Moreover, even if quer-3-LA was less potent than its analogue quer-7-ALA
in the ROS test, it displayed the same protecting efficiency towards cells exposed to light-induced A2E.
Oh et al. [59] observed similar contrasting results, where Resv-DHA displayed no hydrogen peroxide
scavenging activity whereas it showed similar inhibition of DNA scission induced by hydroxyl
radical compared to natural resveratrol. This result confirms the importance of selecting the test
to evaluate the potency of antioxidants. More than one specific assay is needed to evaluate the
antioxidant properties of a newly found compound, as highlighted by Oh et al. [59] on lipophilized
resveratrol derivatives or by Viskupicova and Maliar [57] on lipophenolic rutin derivatives. Moreover,
the antioxidant activity of polyphenols undergo different mechanisms, including direct action of drug
by oxygen radical scavenging but also indirect action through enzymes induction [64] (i.e., Catalase,
ERK pathway, NRF2-KEAP-1) as mentioned by Kang et al. for phloroglucinol [65] or de la Lastra et
al. for resveratrol [66]. In this study, the ability of a derivative to protect RPE cells against oxidative
stress induced by light exposure should be more significant than the most common non-cellular
assays (i.e., DPPH or ABTS) for the selection of new antioxidant derivatives for the development of
pharmacological solution to reduce progression of AMD and Stargardt pathology [4].
Taken together, the different evaluations performed in this work highlight quer-7-ALA as a
promising compound for further evaluations against AMD oxidative stress. Nevertheless, it has
been demonstrated that a double carbonyl and oxidative stress (COS) stress is involved in toxic
mechanisms, leading to photoreceptor death in AMD and Stargardt disease. As previously described
using lipophenolic phloroglucinol, the resorcinol moiety of the A ring of the flavonoid backbone
might be important to display protection against carbonyl stress [26]. As a consequence, quer-3-LA,
having free hydroxyls on the A ring, might also be an interesting lipophenolic derivative to confer
both antioxidant and anti-carbonyl stress properties in a single molecule.
5. Conclusions
Most of the ROS inhibition tests performed on lipophenol derivatives as described in the literature
are performed on non-cellular assay and frequently showed a decrease in the antioxidant properties
of lipophenols. In this work, the test was performed in ARPE-19 cells, where the polyphenol ROS
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scavenging activity was mostly reduced following the PUFA introduction in the structure. However,
we further highlighted the beneficial effect of lipophenol in increasing lipid protection during A2E
photo-oxidation of the RPE cells. The importance of the position of the PUFA was demonstrated
in the flavonoid backbone that influenced either toxicity or activity. Among the lipophenols tested,
quer-7-ALA displayed substantial protection against A2E toxicity in ARPE-19 cells. The levels of
cellular protection were comparable to the one of a lipid antioxidant showing A2E reduction in a mouse
model (Norbixin) [62] or a flavonoid demonstrating in vivo protection against retinal degeneration
induced by blue light exposure [19]. Quer-3-LA also possess interesting antioxidant properties,
which combined with its anti-carbonyl stress activity would be interesting to further evaluate in a
mouse model of retina pathology. We hypothesize the process by which these flavonoid lipophenols
improved their antioxidant activities compared to quercetin, which must pass through cell penetration
or through membrane incorporation. To better address this question, it is essential to investigate
the stability and pharmacokinetics of such derivatives in future. In addition, the mechanisms of the
lipophenol protection must be explored to identify the real target of these new lipophilic antioxidants
and determine their future potential in other retina cell models. In closing, this study highlights the
importance of implementing a variety of cellular assays to evaluate antioxidant potency.
6. Patents
A part of the molecule presented in this work are described in the patent: Lipophenolic flavonoid
derivatives useful to reduce carbonyl and oxidative stresses (COS); EP18305957.5, July 2018.
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